Please assess the completion status of the following clinical trial:

Trial Title: A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be diagnosed with schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria~* Have taken atypical antipsychotics (aripiprazole, olanzapine, risperidone) at least 6 weeks prior to start of study.~* Have Medication Satisfaction Questionnaire (MSQ) score of ≤3~* Competent patients who manage to answer the questionnaires~Exclusion Criteria:~* Have had a history or current symptoms of tardive dyskinesia or neuroleptic malignant syndrome~* Have had relevant history of or current presence of any significant or unstable cardiovascular, respiratory, neurological (including seizures or significant cerebrovascular), renal, hepatic, hematologic, endocrine, immunologic, morbid obesity (BMI≥40), or other systemic disease~* Had received two or more different kind of antipsychotics.~* Had a history of taking paliperidone extended release (ER).~* Allergy or hypersensitivity to risperidone or paliperidone ER.~* Have been on clozapine or long-acting injectable antipsychotic medication during the last 3 months.~* Have had Medication Satisfaction Questionnaire (MSQ) score\>3~* Have been hospitalized for longer than 8 continuous weeks during the past 6 months~* Had history of any severe preexisting gastrointestinal narrowing (pathologic or iatrogenic) or inability to swallow the oral tolerability medication whole with the aid of water for patients requiring oral tolerability testing~* Current substance dependence (DSM-IV) or past history of dependence (more than 6 months)

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Paliperidone ER (Type: EXPERIMENTAL): Immediate initiation of Paliperidone ER for a total of 12 weeks
- Antipsychotics and paliperidone ER (Type: EXPERIMENTAL): Delayed initiation included previous atypical antipsychotics for 8 weeks and then be initiated on paliperidone ER at Day 56 for 4 weeks. The atypical antipsychotics includes aripiprazole, olanzapine and risperidone. These antipsychotics belongs to the class of second generation bipolar atypical antipsychotics.

Based on this trial design, predict the completion outcome and termination type (if applicable).